Advertisement
Loading...

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABTNASDAQ
NaN
NaN
$1.60
$-1.35(-45.76%)
U.S. Market is Open • 11:36

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Stock Competitors & Peer Comparison

See (LABT) competitors and their performances in Stock Market.

Peer Comparison Table: NaN Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LABT$1.96-33.56%9.2MN/AN/AN/A
BSPGX$866.74+0.00%57.5B29.43$29.46N/A
TEQWX$51.08+0.51%45.2B4.63$11.04N/A
TRHZX$193.36+0.59%38.5B29.44$6.57N/A
ILMNV$107.00+1.66%17BN/AN/AN/A
LUBYX$10.02+0.00%16.3BN/AN/AN/A
PMZIX$9.32+0.00%13.6BN/AN/AN/A
SHAPX$36.77+0.82%9.7B29.94$1.23N/A
QLENX$20.20-0.10%8BN/AN/AN/A
VFIRX$9.85+0.00%5.8BN/AN/AN/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LABT vs BSPGX Comparison May 2026

LABT plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LABT stands at 9.2M. In comparison, BSPGX has a market cap of 57.5B. Regarding current trading prices, LABT is priced at $1.96, while BSPGX trades at $866.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LABT currently has a P/E ratio of N/A, whereas BSPGX's P/E ratio is 29.43. In terms of profitability, LABT's ROE is N/A, compared to BSPGX's ROE of N/A. Regarding short-term risk, LABT is more volatile compared to BSPGX. This indicates potentially higher risk in terms of short-term price fluctuations for LABT.Check BSPGX's competition here

Stock price comparison of stocks in the NaN Sector

Loading...

Frequently Asked Questions